Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity
Eight new phenylisoxazole isoniazid derivatives, 3-(2′-fluorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (1), 3-(2′-methoxyphenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (2), 3-(2′-chlorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (3), 3-(3′-clorophenyl)isoxazole-5-carbald...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bbc875c3dcf94f21b784471c292f9569 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bbc875c3dcf94f21b784471c292f9569 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bbc875c3dcf94f21b784471c292f95692021-11-08T02:36:02ZPhenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity2090-907110.1155/2021/6014093https://doaj.org/article/bbc875c3dcf94f21b784471c292f95692021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/6014093https://doaj.org/toc/2090-9071Eight new phenylisoxazole isoniazid derivatives, 3-(2′-fluorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (1), 3-(2′-methoxyphenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (2), 3-(2′-chlorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (3), 3-(3′-clorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (4), 3-(4′-bromophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (5), 5-(4′-methoxiphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (6), 5-(4′-methylphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (7), and 5-(4′-clorophenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (8), have been synthesized and characterized by FT-IR, 1H-NMR, 13C-NMR, and mass spectral data. The 2D NMR (1H-1H NOESY) analysis of 1 and 2 confirmed that these compounds in acetone-d6 are in the trans(E) isomeric form. This evidence is supported by computational calculations which were performed for compounds 1–8, using DFT/B3LYP level with the 6-311++G(d,p) basis set. The in vitro antituberculous activity of all the synthesized compounds was determined against the Mycobacterium tuberculosis standard strains: sensitive H37Rv (ATCC-27294) and resistant TB DM97. All the compounds exhibited moderate bioactivity (MIC = 0.34–0.41 μM) with respect to the isoniazid drug (MIC = 0.91 μM) against the H37Rv sensitive strain. Compounds 6 (X = 4′-OCH3) and 7 (X = 4′-CH3) with MIC values of 12.41 and 13.06 μM, respectively, were about two times more cytotoxic, compared with isoniazid, against the resistant strain TB DM97.Fernando CarrascoWilfredo HernándezOscar ChupayoPatricia SheenMirko ZimicJorge CoronelCeledonio M. ÁlvarezSergio FerreroSandra Oramas-RoyoEvgenia SpodineJesus M. RodillaJuan Z. DávalosHindawi LimitedarticleChemistryQD1-999ENJournal of Chemistry, Vol 2021 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Chemistry QD1-999 |
spellingShingle |
Chemistry QD1-999 Fernando Carrasco Wilfredo Hernández Oscar Chupayo Patricia Sheen Mirko Zimic Jorge Coronel Celedonio M. Álvarez Sergio Ferrero Sandra Oramas-Royo Evgenia Spodine Jesus M. Rodilla Juan Z. Dávalos Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity |
description |
Eight new phenylisoxazole isoniazid derivatives, 3-(2′-fluorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (1), 3-(2′-methoxyphenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (2), 3-(2′-chlorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (3), 3-(3′-clorophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (4), 3-(4′-bromophenyl)isoxazole-5-carbaldehyde isonicotinylhydrazone (5), 5-(4′-methoxiphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (6), 5-(4′-methylphenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (7), and 5-(4′-clorophenyl)isoxazole-3-carbaldehyde isonicotinylhydrazone (8), have been synthesized and characterized by FT-IR, 1H-NMR, 13C-NMR, and mass spectral data. The 2D NMR (1H-1H NOESY) analysis of 1 and 2 confirmed that these compounds in acetone-d6 are in the trans(E) isomeric form. This evidence is supported by computational calculations which were performed for compounds 1–8, using DFT/B3LYP level with the 6-311++G(d,p) basis set. The in vitro antituberculous activity of all the synthesized compounds was determined against the Mycobacterium tuberculosis standard strains: sensitive H37Rv (ATCC-27294) and resistant TB DM97. All the compounds exhibited moderate bioactivity (MIC = 0.34–0.41 μM) with respect to the isoniazid drug (MIC = 0.91 μM) against the H37Rv sensitive strain. Compounds 6 (X = 4′-OCH3) and 7 (X = 4′-CH3) with MIC values of 12.41 and 13.06 μM, respectively, were about two times more cytotoxic, compared with isoniazid, against the resistant strain TB DM97. |
format |
article |
author |
Fernando Carrasco Wilfredo Hernández Oscar Chupayo Patricia Sheen Mirko Zimic Jorge Coronel Celedonio M. Álvarez Sergio Ferrero Sandra Oramas-Royo Evgenia Spodine Jesus M. Rodilla Juan Z. Dávalos |
author_facet |
Fernando Carrasco Wilfredo Hernández Oscar Chupayo Patricia Sheen Mirko Zimic Jorge Coronel Celedonio M. Álvarez Sergio Ferrero Sandra Oramas-Royo Evgenia Spodine Jesus M. Rodilla Juan Z. Dávalos |
author_sort |
Fernando Carrasco |
title |
Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity |
title_short |
Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity |
title_full |
Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity |
title_fullStr |
Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity |
title_full_unstemmed |
Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone Derivatives: Synthesis, Characterization, and Antitubercular Activity |
title_sort |
phenylisoxazole-3/5-carbaldehyde isonicotinylhydrazone derivatives: synthesis, characterization, and antitubercular activity |
publisher |
Hindawi Limited |
publishDate |
2021 |
url |
https://doaj.org/article/bbc875c3dcf94f21b784471c292f9569 |
work_keys_str_mv |
AT fernandocarrasco phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT wilfredohernandez phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT oscarchupayo phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT patriciasheen phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT mirkozimic phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT jorgecoronel phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT celedoniomalvarez phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT sergioferrero phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT sandraoramasroyo phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT evgeniaspodine phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT jesusmrodilla phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity AT juanzdavalos phenylisoxazole35carbaldehydeisonicotinylhydrazonederivativessynthesischaracterizationandantitubercularactivity |
_version_ |
1718443222126034944 |